Related references
Note: Only part of the references are listed.Haplotypes Across ACE and the Risk of Alzheimer's Disease: The Three-City Study
Amélie Bruandet et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: The Cache County Dementia Progression Study
David Peterson et al.
ALZHEIMERS & DEMENTIA (2014)
Phosphorylated Tau-Aβ42 Ratio as a Continuous Trait for Biomarker Discovery for Early-Stage Alzheimer's Disease in Multiplex Immunoassay Panels of Cerebrospinal Fluid
Oscar Harari et al.
BIOLOGICAL PSYCHIATRY (2014)
Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers
Li Shen et al.
BRAIN IMAGING AND BEHAVIOR (2014)
Trans-Signaling Is a Dominant Mechanism for the Pathogenic Actions of Interleukin-6 in the Brain
Iain L. Campbell et al.
JOURNAL OF NEUROSCIENCE (2014)
Multiethnic Meta-Analysis of Genome-Wide Association Studies in > 100 000 Subjects Identifies 23 FibrinogenAssociated Loci but No Strong Evidence of a Causal Association Between Circulating Fibrinogen and Cardiovascular Disease
Maria Sabater-Lleal et al.
CIRCULATION (2013)
Genetic variation associated with circulating monocyte count in the eMERGE Network
David R. Crosslin et al.
HUMAN MOLECULAR GENETICS (2013)
Influence of TSPO Genotype on C-11-PBR28 Standardized Uptake Values
Karmen K. Yoder et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment
K. Nho et al.
MOLECULAR PSYCHIATRY (2013)
Identification of functional variants from whole-exome sequencing, combined with neuroimaging genetics
K Nho et al.
MOLECULAR PSYCHIATRY (2013)
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2013)
GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer's Disease
Carlos Cruchaga et al.
NEURON (2013)
Genetic Loci Associated with Alzheimer's Disease and Cerebrospinal Fluid Biomarkers in a Finnish Case-Control Cohort
Lyzel S. Elias-Sonnenschein et al.
PLOS ONE (2013)
Influence of Genetic Variation on Plasma Protein Levels in Older Adults Using a Multi-Analyte Panel
Sungeun Kim et al.
PLOS ONE (2013)
Mitochondrial Haplotypes Associated with Biomarkers for Alzheimer's Disease
Perry G. Ridge et al.
PLOS ONE (2013)
Mechanisms of HIV Entry into the CNS: Increased Sensitivity of HIV Infected CD14+CD16+ Monocytes to CCL2 and Key Roles of CCR2, JAM-A, and ALCAM in Diapedesis
Dionna W. Williams et al.
PLOS ONE (2013)
Functional IL6R 358Ala Allele Impairs Classical IL-6 Receptor Signaling and Influences Risk of Diverse Inflammatory Diseases
Ricardo C. Ferreira et al.
PLOS GENETICS (2013)
A Genome-Wide Association Study for Coronary Artery Disease Identifies a Novel Susceptibility Locus in the Major Histocompatibility Complex
Robert W. Davies et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2012)
Annotation of functional variation in personal genomes using RegulomeDB
Alan P. Boyle et al.
GENOME RESEARCH (2012)
Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimers disease
Carlos Cruchaga et al.
HUMAN MOLECULAR GENETICS (2012)
Functional analysis of APOE locus genetic variation implicates regional enhancers in the regulation of both TOMM40 and APOE
Lynn M. Bekris et al.
JOURNAL OF HUMAN GENETICS (2012)
CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's Disease
Karin Westin et al.
PLOS ONE (2012)
MultiPhen: Joint Model of Multiple Phenotypes Can Increase Discovery in GWAS
Paul F. O'Reilly et al.
PLOS ONE (2012)
Meta-Analysis of Genome-Wide Association Studies in >80 000 Subjects Identifies Multiple Loci for C-Reactive Protein Levels
Abbas Dehghan et al.
CIRCULATION (2011)
CC Chemokine Receptor 2 Deficiency Aggravates Cognitive Impairments and Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease
Gaelle Naert et al.
JOURNAL OF NEUROSCIENCE (2011)
Identification of IL6R and chromosome 11q13.5 as risk loci for asthma
Manuel A. R. Ferreira et al.
LANCET (2011)
Genome-wide association study of CSF biomarkers Aβ1-42, t-tau, and p-tau181p in the ADNI cohort
S. Kim et al.
NEUROLOGY (2011)
Fine Mapping of Genetic Variants in BIN1, CLU, CR1 and PICALM for Association with Cerebrospinal Fluid Biomarkers for Alzheimer's Disease
John S. K. Kauwe et al.
PLOS ONE (2011)
Alzheimer's Disease: The Challenge of the Second Century
David M. Holtzman et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects
John Q. Trojanowski et al.
ALZHEIMERS & DEMENTIA (2010)
ADAM17-mediated shedding of the IL6R induces cleavage of the membrane stub by γ-secretase
Athena Chalaris et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Exploration of disease mechanism in acute kidney injury using a multiplex bead array assay: a nested case-control pilot study
Orfeas Liangos et al.
BIOMARKERS (2010)
Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study
Mi-Ryung Han et al.
BMC NEUROLOGY (2010)
Interleukin-6 receptor gene polymorphisms were associated with sporadic Alzheimer's disease in Chinese Han
Min Wang et al.
BRAIN RESEARCH (2010)
The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases
Gregory Conductier et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
A method and server for predicting damaging missense mutations
Ivan A. Adzhubei et al.
NATURE METHODS (2010)
CALHM1 P86L polymorphism does not alter amyloid-β or tau in cerebrospinal fluid
Vilmantas Giedraitis et al.
NEUROSCIENCE LETTERS (2010)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
A genome-wide association study identifies new loci for ACE activity: potential implications for response to ACE inhibitor
C-M Chung et al.
PHARMACOGENOMICS JOURNAL (2010)
SNPs Associated with Cerebrospinal Fluid Phospho-Tau Levels Influence Rate of Decline in Alzheimer's Disease
Carlos Cruchaga et al.
PLOS GENETICS (2010)
Cerebrospinal Fluid Biomarkers and Rate of Cognitive Decline in Very Mild Dementia of the Alzheimer Type
Barbara J. Snider et al.
ARCHIVES OF NEUROLOGY (2009)
Genome-Wide Association Scan Identifies Variants near Matrix Metalloproteinase (MMP) Genes on Chromosome 11q21-22 Strongly Associated With Serum MMP-1 Levels
Yu-Ching Cheng et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2009)
Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid beta
John S. K. Kauwe et al.
NEUROGENETICS (2009)
Relationships between biomarkers in aging and dementia
W. J. Jagust et al.
NEUROLOGY (2009)
An age effect on the association of common variants of ACE with Alzheimer's disease
Nicole Helbecque et al.
NEUROSCIENCE LETTERS (2009)
CCL2 Accelerates Microglia-Mediated Aβ Oligomer Formation and Progression of Neurocognitive Dysfunction
Tomomi Kiyota et al.
PLOS ONE (2009)
Missing data imputation and haplotype phase inference for genome-wide association studies
Sharon R. Browning
HUMAN GENETICS (2008)
Matrix metalloproteinase 3 haplotypes and dementia and Alzheimer's disease - The Rotterdam Study
Christiane Reitz et al.
NEUROBIOLOGY OF AGING (2008)
Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition
John S. K. Kauwe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A genome-wide association study identifies protein quantitative trait loci (pQTLs)
David Melzer et al.
PLOS GENETICS (2008)
Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues
J. T-J Huang et al.
MOLECULAR PSYCHIATRY (2008)
Interleukin-6 receptor gene variations, plasma interleukin-6 levels, and type 2 diabetes in US women
Lu Qi et al.
DIABETES (2007)
PLINK: A tool set for whole-genome association and population-based linkage analyses
Shaun Purcell et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Angiotensin-converting enzyme converts amyloid β-protein 1-42 (Aβ1-42) to Aβ1-40, and its inhibition enhances brain aβ deposition
Kun Zou et al.
JOURNAL OF NEUROSCIENCE (2007)
Chemokine regulation of atherosclerosis
Jana Barlic et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Cytokines in the pathogenesis of rheumatoid arthritis
Iain B. McInnes et al.
NATURE REVIEWS IMMUNOLOGY (2007)
GenABEL: an R library for genome-wide association analysis
Yurii S. Aulchenko et al.
BIOINFORMATICS (2007)
Extreme cerebrospinal fluid amyloid β levels identify family with late-onset Alzheimer's disease presenilin 1 mutation
John S. K. Kauwe et al.
ANNALS OF NEUROLOGY (2007)
Cerebrospinal fluid tau/β-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults
Anne M. Fagan et al.
ARCHIVES OF NEUROLOGY (2007)
Framingham Heart Study genome-wide association: results for pulmonary function measures
Jemma B. Wilk et al.
BMC MEDICAL GENETICS (2007)
Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease
Daniela Galimberti et al.
NEUROBIOLOGY OF AGING (2006)
Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-β peptide catabolism
Ke-Jie Yin et al.
JOURNAL OF NEUROSCIENCE (2006)
Analysis of functional polymorphisms of metalloproteinase genes in persons with vascular dementia and Alzheimer's disease
Andrea Flex et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2006)
Matrix metalloproteinase-9 degrades amyloid-β fibrils in vitro and compact plaques in situ
Ping Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Principal components analysis corrects for stratification in genome-wide association studies
Alkes L. Price et al.
NATURE GENETICS (2006)
Genetic variation in the CCL18-CCL3-CCL4 chemokine gene cluster influences HIV type 1 transmission and AIDS disease progression
William S. Modi et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Degradation of the Alzheimer disease amyloid β-peptide by metal-dependent up-regulation of metalloprotease activity
Anthony R. White et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia
M Bibl et al.
BRAIN (2006)
Association of Polymorphisms in the angiotensin-converting enzyme gene with Alzheimer disease in an Israeli Arab community
Y Meng et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans
AM Fagan et al.
ANNALS OF NEUROLOGY (2006)
Amyloid β-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor
ML Hemming et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Interleukin-6 polymorphism is associated with more aggressive prostate cancer
DF Tan et al.
JOURNAL OF UROLOGY (2005)
The N-terminal active centre of human angiotensin-converting enzyme degrades Alzheimer amyloid β-peptide
R Oba et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Common variants of ACE contribute to variable age-at-onset of Alzheimer's disease
PG Kehoe et al.
HUMAN GENETICS (2004)
Interaction between matrix metalloproteinase 3 and the ε4 allele of apolipoprotein E increases the risk of Alzheimer's disease in Finns
MS Saarela et al.
NEUROSCIENCE LETTERS (2004)
Expression of CCR2 on monocytes and macrophages in chronically inflamed skin in atopic dermatitis and psoriasis
C Vestergaard et al.
ACTA DERMATO-VENEREOLOGICA (2004)
Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis
S Dorr et al.
ARTHRITIS RESEARCH & THERAPY (2004)
SIFT: predicting amino acid changes that affect protein function
PC Ng et al.
NUCLEIC ACIDS RESEARCH (2003)
Adult mouse astrocytes degrade amyloid-β in vitro and in situ
T Wyss-Coray et al.
NATURE MEDICINE (2003)
Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10
TCA Tolboom et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
IL-6 in autoimmune disease and chronic inflammatory proliferative disease
K Ishihara et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
Amyloid-β-induced chemokine production in primary human macrophages and astrocytes
HA Smits et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Angiotensin-converting enzyme degrades Alzheimer amyloid β-peptide (Aβ);: Retards Aβ aggregation, deposition, fibril formation, and inhibits cytotoxicity.
JG Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Inflammation and Alzheimer's disease
H Akiyama et al.
NEUROBIOLOGY OF AGING (2000)
Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer's disease brain
Y Yoshiyama et al.
ACTA NEUROPATHOLOGICA (2000)
Share Paper
